Lv54
890 积分 2024-06-19 加入
Targeted protein degradation: expanding the toolbox
7小时前
已完结
Bridged PROTAC, DNA-based PROTAC and hydrophobic tag technologies for targeted protein degradation
8天前
已完结
Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications
8天前
已完结
Targeted protein degradation for cancer therapy
8天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
17天前
已完结
Cross-priming in cancer immunology and immunotherapy
17天前
已完结
Epigenetic Therapies for Cancer
1个月前
已完结
Synthetic lethal strategies for the development of cancer therapeutics
1个月前
已完结
Targeting the epigenetic regulation of antitumour immunity
1个月前
已完结
Targeting and engineering long non-coding RNAs for cancer therapy
1个月前
已完结
皖公网安备34019202002308
